Multiple sclerosis and related disorders · 2020
Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice.
СтатьяОбзорConsensus StatementНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Carnero Contentti Edgar, Rojas Juan Ignacio, Cristiano Edgardo, Marques Vanessa Daccach, Flores-Rivera José, Lana-Peixoto Marco, Navas Carlos, Papais-Alvarenga Regina, Sato Douglas K, Soto de Castillo Ibis, Correale Jorge
Аннотация
BACKGROUND: During the last two decades, neuromyelitis optica spectrum disorder (NMOSD) has undergone important changes, with new diagnostic markers and criteria, better recognition of clinical phenotypes, better disease prognosis and new therapeutic approaches. Consequently, management of NMOSD patients in Latin American (LATAM) has become more complex and challenging in clinical practice. In making these consensus recommendations, the aim was to review how the disease should be managed and treated among LATAM patients, in order to improve long-term outcomes in these populations.
METHODS: A panel of LATAM neurologists who are experts in demyelinating diseases and dedicated to management and care of NMOSD patients gathered virtually during 2019 and 2020 to make consensus recommendations on management and treatment of NMOSD patients in LATAM. To achieve this consensus, the RAND/UCLA methodology for reaching formal consensus was used.
RESULTS: The recommendations focused on diagnosis and differential diagnoses, disease prognosis, tailored treatment, identification of suboptimal treatment response and special circumstances management. They were based on published evidence and expert opinions.
CONCLUSIONS: The recommendations of these consensus guidelines seek to optimize management and specific treatment of NMOSD patients in LATAM.
METHODS: A panel of LATAM neurologists who are experts in demyelinating diseases and dedicated to management and care of NMOSD patients gathered virtually during 2019 and 2020 to make consensus recommendations on management and treatment of NMOSD patients in LATAM. To achieve this consensus, the RAND/UCLA methodology for reaching formal consensus was used.
RESULTS: The recommendations focused on diagnosis and differential diagnoses, disease prognosis, tailored treatment, identification of suboptimal treatment response and special circumstances management. They were based on published evidence and expert opinions.
CONCLUSIONS: The recommendations of these consensus guidelines seek to optimize management and specific treatment of NMOSD patients in LATAM.